RETINOL BINDING PROTEIN - ANVISA Registration 81546350041

Access comprehensive regulatory information for RETINOL BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81546350041 and manufactured by Nanosens Ltda. The registration is held by Nanosens Ltda with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including Nanosens Ltda, TRIMERO DIAGNOSTICS, S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.